Search Result

Results for "

LAG-3

" in MedChemExpress (MCE) Product Catalog:

By Targets:	LAG-3 (27) Adenosine Receptor (1) Btk (1) CXCR (1) Eukaryotic Initiation Factor (eIF) (1) Itk (1) MAP4K (1) PD-1/PD-L1 (3) Small Interfering RNA (siRNA) (3)
By Research Areas:	Cancer (22) Infection (1) Inflammation/Immunology (14)
Oligonucleotides:	Rat Pre-designed siRNA Sets (1) Mouse Pre-designed siRNA Sets (1) Human Pre-designed siRNA Sets (1) siRNAs (3)

Inhibitors & Agonists

Peptides

Inhibitory Antibodies

Recombinant Proteins

Antibodies

Oligonucleotides

Targets Recommended: LAG-3

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-162811

LAG-3 biner 1	LAG-3	Cancer
LAG-3 biner 1 (compound 3) is a small molecule ligand (K_d=1.23 μM) for the immune checkpoint lymphocyte activation gene 3 (LAG-3). LAG-3 biner 1 can be used in the research of cancer diagnosis targeting *LAG-3* .

HY-P99141

*Anti-Mouse LAG-3* Antibody (C9B7W)**	LAG-3	Inflammation/Immunology
Anti-Mouse LAG-3 is an anti-mouse LAG-3 IgG1 antibody inhibitor derived from host Rat.

HY-P99617

Fianlimab REGN3767	LAG-3	Inflammation/Immunology Cancer
Fianlimab (REGN3767) is a human monoclonal antibody that targets the immune checkpoint receptor LAG-3 on T cells and has anti-tumour activity .

HY-P10835

LAG-3 cyclic peptide inhibitor C25	LAG-3	Cancer
LAG-3 cyclic peptide inhibitor C25 is a *LAG-3* inhibitor. LAG-3 cyclic peptide inhibitor C25 has a high affinity with human *LAG-3* protein with a K_d value of 0.66 μM. LAG-3 cyclic peptide inhibitor C25 can block the interaction of *LAG-3* with HLA-DR (MHC-II) and activate CD8 ⁺ T cells. LAG-3 cyclic peptide inhibitor C25 can be used in the study of cancer .

HY-P10837

LAG-3 cyclic peptide inhibitor 12	LAG-3	Inflammation/Immunology Cancer
LAG-3 cyclic peptide inhibitor 12 (Cyclic peptide 12) is an inhibitor of *LAG-3* with an IC₅₀ value of 4.45 μM and a K_i value of 2.66 µM .

HY-RS16686

Lag3 Mouse Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Lag3 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Lag3 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Lag3 Mouse Pre-designed siRNA Set A Lag3 Mouse Pre-designed siRNA Set A

HY-RS07492

LAG3 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
LAG3 Human Pre-designed siRNA Set A contains three designed siRNAs for LAG3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LAG3 Human Pre-designed siRNA Set A LAG3 Human Pre-designed siRNA Set A

HY-RS23121

Lag3 Rat Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Lag3 Rat Pre-designed siRNA Set A contains three designed siRNAs for Lag3 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

Lag3 Rat Pre-designed siRNA Set A Lag3 Rat Pre-designed siRNA Set A

HY-P990204

*Anti-Mouse LAG-3* (D265A) Antibody (C9B7W)**	LAG-3	Others
Anti-Mouse LAG-3 (D265A) Antibody (C9B7W) is a mouse-derived IgG1, κ type antibody inhibitor, targeting to mouse LAG-3.

HY-P99736

Miptenalimab BI-754111	LAG-3	Cancer
Miptenalimab (BI-754111) is an anti-human *LAG-3* antibody (K_D: 88.6 nM for h LAG-3). Miptenalimab blocks the interaction of LAG-3 with its ligand MHC-II .

HY-P99922

Encelimab	LAG-3	Cancer
Encelimab is an anti-LAG3 antibody. Encelimab blocks the interaction between LAG-3 and MHC II, and enhances T-cell activation. Encelimab alone or in combination with an anti-PD-1 antibody reduces tumor size in a lymphoma mice model (A20 cell xenograft) .

HY-P99613

Favezelimab MK-4280	LAG-3	Cancer
Favezelimab (MK-4280) is a humanized monoclonal antibody targeting *LAG-3. Favezelimab blocks the interaction between LAG-3* and its ligand MHC class II. Favezelimab has the potential for colorectal cancer (CRC) research in combination with the PD-L1 inhibitor Pembrolizumab (HY-P9902). Recommend Isotype Controls: Human IgG4 (S228P) kappa, Isotype Control (HY-P99003) .

HY-P99156

Relatlimab BMS-986016	LAG-3	Cancer
Relatlimab (BMS-986016) is a human monoclonal antibody *anti-LAG-3* antibody generated by immunization of transgenic mice bearing human immunoglobulin miniloci with recombinant LAG-3 protein. Relatlimab blocks LAG-3/MHC II interaction with an IC₅₀ value of 0.67 nM and LAG-3/FGL1 interaction with an IC₅₀ value of 0.019 nM. Relatlimab can be used in research of cancer .

HY-P99027

Ieramilimab LAG525; IMP701	LAG-3	Cancer
Ieramilimab (LAG525; IMP701) is a humanized IgG4 monoclonal antibody that binds to *LAG-3, resulting in inhibition of LAG-3* interaction with MHC-II molecules .

HY-P990046

Tuparstobart Incagn-02385	LAG-3	Inflammation/Immunology
Tuparstobart (Incagn-02385) is an IgG1κ antibody targeting *LAG-3. LAG-3* is an immune checkpoint receptor protein mainly expressed on activated T cells, NK cells, B cells and plasmacytoid dendritic cells .

HY-P990740

Fanastomig EMB-02; EMB-02	PD-1/PD-L1 LAG-3	Inflammation/Immunology
Fanastomig is an anti-PDCD1/LAG3 monoclonal antibody .

HY-P99573

Tebotelimab MGD-013	LAG-3	Inflammation/Immunology Cancer
Tebotelimab (MGD-013) is a humanized IgG4κ bispecific *PD-1/LAG-3* dual-affinity re-targeting (DART) antibody. Tebotelimab binds cell-surface expressed PD-1 and LAG-3 with EC₅₀s of 1.65 nM and 0.41 nM in NS0 cells, respectively. Tebotelimab blocks PD-1/PD-L1, PD-1/PD-L2 and LAG-3/HLA (MHC-II) interactions and PD-1 signaling. Tebotelimab restores exhausted T-cell responses and and enhances antitumour immunity ^[3].

HY-P991299

ENUM006	LAG-3	Cancer
ENUM006 is a human monoclonal antibody (mAb) targeting CD223/LAG3 .

HY-P991298

DNV-3	LAG-3	Cancer
DNV-3 is a human monoclonal antibody (mAb) targeting CD223/LAG3 .

HY-164308

SA-15-P	LAG-3	Inflammation/Immunology
SA-15-P inhibits *LAG-3/MHCII* and *LAG-3/FGL1* interactions with IC₅₀ values of 4.21 and 6.52 μM respectively. LAG-3/MHCII interaction is a target for immunotherapies .

HY-P991297

AM0003		Cancer
AM0003 is a human monoclonal antibody (mAb) targeting CD223/LAG3. AM0003 can be used in the study of advanced solid tumors .

HY-P991303

TQB-2223 Sym022; S 95017		Cancer
TQB-2223 is a human monoclonal antibody (mAb) targeting CD223/LAG3. TQB-2223 can be used in the study of Hodgkin lymphoma .

HY-P991302

KL-A289	LAG-3	Cancer
KL-A289 is a human monoclonal antibody (mAb) targeting CD223/LAG3. KL-A289 can be used in the study of metastatic GC .

HY-P99354

Bavunalimab Anti-Human CTLA4xLAG3	LAG-3	Inflammation/Immunology Cancer
Bavunalimab (Anti-Human CTLA4xLAG3) is a bispecific human anti-CTLA-4/LAG-3 monoclonal antibody. Bavunalimab activates T cells in NSG mice. Bavunalimab can be used for the research of cancer .

HY-P990700

Tobemstomig RO-7247669; RG-6139	PD-1/PD-L1 LAG-3	Inflammation/Immunology
Tobemstomig is an anti-PDCD1/LAG3 human IgG1 κ monoclonal antibody . Recommend Isotype Controls: Human IgG1 kappa, Isotype Control (HY-P99001).

HY-P990912

Cugrastomig	LAG-3	Inflammation/Immunology
HY-P990912 is an *PDCD1/LAG3*-targeting IgG1κ-[scFv-heavy -κ]2 type chimeric human and humanized antibody .

HY-P990968

Alcestobart	LAG-3	Inflammation/Immunology
HY-P990968 is an *LAG3*-targeting IgG4κ type human antibody, the recommed isotype control is Human IgG4 (S228P) kappa, Isotype Control (HY-P99003) .

HY-P990976

Brivestobart	LAG-3	Inflammation/Immunology
HY-P990976 is an *LAG3*-targeting IgG4κ type human antibody, the recommed isotype control is Human IgG4 (S228P) kappa, Isotype Control (HY-P99003) .

HY-P991300

GSK2831781	LAG-3	Cancer
GSK2831781 is a human IgG1 monoclonal antibody (mAb) targeting CD223/LAG3. GSK2831781 can be used in the study of ulcerative colitis Recommend Isotype Controls: Human IgG1 kappa, Isotype Control (HY-P99001) .

HY-P991301

IMP-761	LAG-3	Cancer
IMP-761 is a human IgG4 monoclonal antibody (mAb) targeting CD223/LAG3. IMP-761 binds to D1 of human LAG32. Recommend Isotype Controls: Human IgG4 kappa, Isotype Control (HY-P99003) .

HY-108691

PF-06465469 2 Publications Verification	Itk Btk CXCR PD-1/PD-L1 LAG-3	Cancer
PF-06465469 is a covalent inhibitor of ITK with an IC₅₀ of 2 nM. PF-06465469 also inhibits BTK. PF-06465469 inhibits cell migration in response to CXCL12. PF-06465469 decreases PD-1 and *LAG-3* expression. PF-06465469 can be used to study leukemia and T-cell lymphoma .

HY-P990750

Negalstobart	LAG-3	Inflammation/Immunology
Negalstobart is an anti-LAG3 human IgG4 κ monoclonal antibody . Recommend Isotype Controls: Human IgG4 (S228P) kappa, Isotype Control (HY-P99003).

HY-149916

A2AR-antagonist-1	Adenosine Receptor	Cancer
A2AR-antagonist-1 (compound 38) is an orally active adenosine A2A receptor (A2AR) antagonist (IC₅₀=29 nM). A2AR-antagonist-1 exhibits anti-tumor activity and mouse liver microsomal metabolic stability (t_1/2=86.1 min). A2AR-antagonist-1 is also a T cells activator, via inhibiting immunosuppressive molecules (LAG-3 and TIM-3) and enhancing effector molecules (GZMB, IFNG, and IL-2) .

HY-145240

eIF4E-IN-1	Eukaryotic Initiation Factor (eIF)	Infection Cancer
eIF4E-IN-1 is a potent inhibitor of eIF4E. eIF4E-IN-1 inhibits immunosuppression components such as immune checkpoint proteins PD-1, PD-L1, LAG3, TIM3, and/or IDO, in order to inhibit or release immune suppression in certain diseases, such as cancer and infectious disease (extracted from patent WO2021003194A1, compound Y) .

HY-144088

ZYF0033 HPK1-IN-22	MAP4K	Inflammation/Immunology Cancer
ZYF0033 is an orally active inhibitor of the hematopoietic progenitor cell kinase HPK1 with an IC50 of less than 10 nM based on the phosphorylation inhibition of MBP protein. ZYF0033 promotes anti-cancer immune responses and reduces phosphorylation of SLP76 (serine 376). ZYF0033 inhibits tumor growth in the 4T-1 syngeneic mouse model and leads to increased intratumoral infiltration of DCs, NK cells, and CD107a ⁺CD8 ⁺ T cells, but not T cells, PD-1 ⁺CD8 ⁺ T cells, TIM-3 ⁺CD8 ⁺ Infiltration of T cells and LAG3 ⁺CD8 ⁺ T cells was reduced .

Cat. No.	Product Name	Target	Research Area

HY-P10835

LAG-3 cyclic peptide inhibitor C25	LAG-3	Cancer
LAG-3 cyclic peptide inhibitor C25 is a *LAG-3* inhibitor. LAG-3 cyclic peptide inhibitor C25 has a high affinity with human *LAG-3* protein with a K_d value of 0.66 μM. LAG-3 cyclic peptide inhibitor C25 can block the interaction of *LAG-3* with HLA-DR (MHC-II) and activate CD8 ⁺ T cells. LAG-3 cyclic peptide inhibitor C25 can be used in the study of cancer .

HY-P10837

LAG-3 cyclic peptide inhibitor 12	LAG-3	Inflammation/Immunology Cancer
LAG-3 cyclic peptide inhibitor 12 (Cyclic peptide 12) is an inhibitor of *LAG-3* with an IC₅₀ value of 4.45 μM and a K_i value of 2.66 µM .

Cat. No.	Product Name	Target	Research Area

HY-P99141

*Anti-Mouse LAG-3* Antibody (C9B7W)**	LAG-3	Inflammation/Immunology
Anti-Mouse LAG-3 is an anti-mouse LAG-3 IgG1 antibody inhibitor derived from host Rat.

HY-P99617

Fianlimab REGN3767	LAG-3	Inflammation/Immunology Cancer
Fianlimab (REGN3767) is a human monoclonal antibody that targets the immune checkpoint receptor LAG-3 on T cells and has anti-tumour activity .

HY-P99922

Encelimab	LAG-3	Cancer
Encelimab is an anti-LAG3 antibody. Encelimab blocks the interaction between LAG-3 and MHC II, and enhances T-cell activation. Encelimab alone or in combination with an anti-PD-1 antibody reduces tumor size in a lymphoma mice model (A20 cell xenograft) .

HY-P99613

Favezelimab MK-4280	LAG-3	Cancer
Favezelimab (MK-4280) is a humanized monoclonal antibody targeting *LAG-3. Favezelimab blocks the interaction between LAG-3* and its ligand MHC class II. Favezelimab has the potential for colorectal cancer (CRC) research in combination with the PD-L1 inhibitor Pembrolizumab (HY-P9902). Recommend Isotype Controls: Human IgG4 (S228P) kappa, Isotype Control (HY-P99003) .

HY-P99156

Relatlimab BMS-986016	LAG-3	Cancer
Relatlimab (BMS-986016) is a human monoclonal antibody *anti-LAG-3* antibody generated by immunization of transgenic mice bearing human immunoglobulin miniloci with recombinant LAG-3 protein. Relatlimab blocks LAG-3/MHC II interaction with an IC₅₀ value of 0.67 nM and LAG-3/FGL1 interaction with an IC₅₀ value of 0.019 nM. Relatlimab can be used in research of cancer .

HY-P99027

Ieramilimab LAG525; IMP701	LAG-3	Cancer
Ieramilimab (LAG525; IMP701) is a humanized IgG4 monoclonal antibody that binds to *LAG-3, resulting in inhibition of LAG-3* interaction with MHC-II molecules .

HY-P990204

*Anti-Mouse LAG-3* (D265A) Antibody (C9B7W)**	LAG-3	Others
Anti-Mouse LAG-3 (D265A) Antibody (C9B7W) is a mouse-derived IgG1, κ type antibody inhibitor, targeting to mouse LAG-3.

HY-P99736

Miptenalimab BI-754111	LAG-3	Cancer
Miptenalimab (BI-754111) is an anti-human *LAG-3* antibody (K_D: 88.6 nM for h LAG-3). Miptenalimab blocks the interaction of LAG-3 with its ligand MHC-II .

HY-P990046

Tuparstobart Incagn-02385	LAG-3	Inflammation/Immunology
Tuparstobart (Incagn-02385) is an IgG1κ antibody targeting *LAG-3. LAG-3* is an immune checkpoint receptor protein mainly expressed on activated T cells, NK cells, B cells and plasmacytoid dendritic cells .

HY-P990740

Fanastomig EMB-02; EMB-02	PD-1/PD-L1 LAG-3	Inflammation/Immunology
Fanastomig is an anti-PDCD1/LAG3 monoclonal antibody .

HY-P99573

Tebotelimab MGD-013	LAG-3	Inflammation/Immunology Cancer
Tebotelimab (MGD-013) is a humanized IgG4κ bispecific *PD-1/LAG-3* dual-affinity re-targeting (DART) antibody. Tebotelimab binds cell-surface expressed PD-1 and LAG-3 with EC₅₀s of 1.65 nM and 0.41 nM in NS0 cells, respectively. Tebotelimab blocks PD-1/PD-L1, PD-1/PD-L2 and LAG-3/HLA (MHC-II) interactions and PD-1 signaling. Tebotelimab restores exhausted T-cell responses and and enhances antitumour immunity ^[3].

HY-P991299

ENUM006	LAG-3	Cancer
ENUM006 is a human monoclonal antibody (mAb) targeting CD223/LAG3 .

HY-P991298

DNV-3	LAG-3	Cancer
DNV-3 is a human monoclonal antibody (mAb) targeting CD223/LAG3 .

HY-P991297

AM0003		Cancer
AM0003 is a human monoclonal antibody (mAb) targeting CD223/LAG3. AM0003 can be used in the study of advanced solid tumors .

HY-P991303

TQB-2223 Sym022; S 95017		Cancer
TQB-2223 is a human monoclonal antibody (mAb) targeting CD223/LAG3. TQB-2223 can be used in the study of Hodgkin lymphoma .

HY-P991302

KL-A289	LAG-3	Cancer
KL-A289 is a human monoclonal antibody (mAb) targeting CD223/LAG3. KL-A289 can be used in the study of metastatic GC .

HY-P99354

Bavunalimab Anti-Human CTLA4xLAG3	LAG-3	Inflammation/Immunology Cancer
Bavunalimab (Anti-Human CTLA4xLAG3) is a bispecific human anti-CTLA-4/LAG-3 monoclonal antibody. Bavunalimab activates T cells in NSG mice. Bavunalimab can be used for the research of cancer .

HY-P990700

Tobemstomig RO-7247669; RG-6139	PD-1/PD-L1 LAG-3	Inflammation/Immunology
Tobemstomig is an anti-PDCD1/LAG3 human IgG1 κ monoclonal antibody . Recommend Isotype Controls: Human IgG1 kappa, Isotype Control (HY-P99001).

HY-P990912

Cugrastomig	LAG-3	Inflammation/Immunology
HY-P990912 is an *PDCD1/LAG3*-targeting IgG1κ-[scFv-heavy -κ]2 type chimeric human and humanized antibody .

HY-P990968

Alcestobart	LAG-3	Inflammation/Immunology
HY-P990968 is an *LAG3*-targeting IgG4κ type human antibody, the recommed isotype control is Human IgG4 (S228P) kappa, Isotype Control (HY-P99003) .

HY-P990976

Brivestobart	LAG-3	Inflammation/Immunology
HY-P990976 is an *LAG3*-targeting IgG4κ type human antibody, the recommed isotype control is Human IgG4 (S228P) kappa, Isotype Control (HY-P99003) .

HY-P991300

GSK2831781	LAG-3	Cancer
GSK2831781 is a human IgG1 monoclonal antibody (mAb) targeting CD223/LAG3. GSK2831781 can be used in the study of ulcerative colitis Recommend Isotype Controls: Human IgG1 kappa, Isotype Control (HY-P99001) .

HY-P991301

IMP-761	LAG-3	Cancer
IMP-761 is a human IgG4 monoclonal antibody (mAb) targeting CD223/LAG3. IMP-761 binds to D1 of human LAG32. Recommend Isotype Controls: Human IgG4 kappa, Isotype Control (HY-P99003) .

HY-P990750

Negalstobart	LAG-3	Inflammation/Immunology
Negalstobart is an anti-LAG3 human IgG4 κ monoclonal antibody . Recommend Isotype Controls: Human IgG4 (S228P) kappa, Isotype Control (HY-P99003).

Species:	Human (8) Marmoset (1) Mouse (3) Rat (1) Cynomolgus (3) Canine (1)
Tag:	His (9) Tag Free (1) Avi (3) Fc (7) Flag (1)
Source:	HEK293 (17)

Cat. No.	Compare	Product Name	Species	Source

HY-P70723

	LAG-3 Protein, Human (HEK293, Fc) Lymphocyte activation gene 3 protein; LAG3; LAG-3; Protein FDC; CD223	Human	HEK293
	LAG-3 (lymphocyte activating gene 3) protein is an inhibitory receptor on antigen-activated T cells and is critical for immune regulation. LAG-3 binds to FGL1 and transmits inhibitory signals that negatively affect CD8(+) and CD4(+) T cell proliferation, activation, and effector functions. LAG-3 Protein, Human (HEK293, Fc) is the recombinant human-derived LAG-3 protein, expressed by HEK293 , with C-hFc labeled tag.

HY-P70722

	LAG-3 Protein, Human (HEK293, His) Lymphocyte activation gene 3 protein; LAG3; LAG-3; Protein FDC; CD223	Human	HEK293
	LAG-3 (lymphocyte activating gene 3) protein is an inhibitory receptor on antigen-activated T cells and is critical for immune regulation. LAG-3 binds to FGL1 and transmits inhibitory signals that negatively affect CD8(+) and CD4(+) T cell proliferation, activation, and effector functions. LAG-3 Protein, Human (HEK293, His) is the recombinant human-derived LAG-3 protein, expressed by HEK293 , with C-6*His labeled tag.

HY-P72530

	LAG-3 Protein, Cynomolgus (428a.a, HEK293, His) Lymphocyte Activating 3; LAG3; LAG-3; CD223	Cynomolgus	HEK293
	LAG-3 Protein, expressed on antigen-activated T-cells, delivers inhibitory signals by binding to ligands like FGL1. LAG-3 Protein associates with CD3-TCR, directly inhibiting T-cell activation. LAG-3 Protein, Cynomolgus (428a.a, HEK293, His) is a recombinant protein dimer complex containing cynomolgus-derived LAG-3 protein, expressed by HEK293 , with N-8*His labeled tag. LAG-3 Protein, Cynomolgus (428a.a, HEK293, His), has molecular weight of 55-65 kDa.

HY-P78656

	LAG-3 Protein, Marmoset (HEK293, His) LAG3; CD223; FDC	Marmoset	HEK293
	LAG-3 (lymphocyte activation gene 3) protein is expressed on antigen-activated T cells and transmits inhibitory signals by binding to ligands such as FGL1. FGL1 is the main ligand responsible for the suppressive function of LAG3 T cells. LAG-3 Protein, Marmoset (HEK293, His) is the recombinant Marmoset-derived LAG-3 protein, expressed by HEK293 , with C-10*His labeled tag.

HY-P78720

	LAG-3 Protein, Mouse (419a.a, HEK293, His) Lymphocyte activation gene 3 protein; LAG3; LAG-3; Protein FDC; CD223	Mouse	HEK293
	LAG-3 (lymphocyte activation gene 3) protein is expressed on antigen-activated T cells and transmits inhibitory signals by binding to ligands such as FGL1.FGL1 is the main ligand responsible for the suppressive function of LAG3 T cells.LAG-3 Protein, Mouse (HEK293, His) is the recombinant mouse-derived LAG-3 protein, expressed by HEK293 , with C-His labeled tag.

HY-P70735

	LAG-3 Protein, Human (HEK293, mFc) Lymphocyte activation gene 3 protein; LAG3; LAG-3; Protein FDC; CD223	Human	HEK293
	LAG-3 (lymphocyte activating gene 3) protein is an inhibitory receptor on antigen-activated T cells and is critical for immune regulation. LAG-3 binds to FGL1 and transmits inhibitory signals that negatively affect CD8(+) and CD4(+) T cell proliferation, activation, and effector functions. LAG-3 Protein, Human (HEK293, mFc) is the recombinant human-derived LAG-3 protein, expressed by HEK293 , with C-mFc labeled tag.

HY-P704247

	LAG-3 Protein, Cynomolgus (HEK293, mFc) Lymphocyte Activating 3; LAG3; LAG-3; CD223	Cynomolgus	HEK293

HY-P704261

	LAG-3 Protein, Cynomolgus (428a.a, HEK293, Fc) Lymphocyte Activating 3; LAG3; LAG-3; CD223	Cynomolgus	HEK293

HY-P704298

	LAG-3 Protein, Human (HEK293, Llama Fc) Lymphocyte activation gene 3 protein; LAG3; LAG-3; Protein FDC; CD223	Human	HEK293

HY-P73844

	LAG-3 Protein, Mouse (HEK293) Lymphocyte activation gene 3 protein; Protein FDC; CD223	Mouse	HEK293
	LAG-3 (lymphocyte activation gene 3) protein is expressed on antigen-activated T cells and transmits inhibitory signals by binding to ligands such as FGL1.FGL1 is the main ligand responsible for the suppressive function of LAG3 T cells.LAG-3 Protein, Mouse (HEK293) is the recombinant mouse-derived LAG-3 protein, expressed by HEK293 , with tag free.

HY-P73843

	LAG-3 Protein, Mouse (HEK293, Fc) Lymphocyte activation gene 3 protein; Protein FDC; CD223	Mouse	HEK293
	LAG-3 (lymphocyte activation gene 3) protein is expressed on antigen-activated T cells and transmits inhibitory signals by binding to ligands such as FGL1.FGL1 is the main ligand responsible for the suppressive function of LAG3 T cells.LAG-3 Protein, Mouse (HEK293, Fc) is the recombinant mouse-derived LAG-3 protein, expressed by HEK293 , with C-hFc labeled tag.

HY-P74788

	LAG-3 Protein, Rat (HEK293, His) Lymphocyte activation gene 3 protein; Protein FDC; CD223	Rat	HEK293
	LAG-3 (lymphocyte activation gene 3) protein is an inhibitory receptor on antigen-activated T cells, which transmits inhibitory signals by binding to ligands such as FGL1. LAG-3 is associated with CD3-TCR at the immune synapse, hinders T cell activation, and may cooperate with PDCD1/PD-1 to act as a co-receptor for PD-1. LAG-3 Protein, Rat (HEK293, His) is the recombinant rat-derived LAG-3 protein, expressed by HEK293 , with C-His labeled tag.

HY-P72389

	LAG-3 Protein, Human (Biotinylated, HEK293, His-Avi) Lymphocyte activation gene 3 protein; Protein FDC; CD223	Human	HEK293
	LAG-3 (lymphocyte activating gene 3) protein is an inhibitory receptor on antigen-activated T cells and is critical for immune regulation. LAG-3 binds to FGL1 and transmits inhibitory signals that negatively affect CD8(+) and CD4(+) T cell proliferation, activation, and effector functions. LAG-3 Protein, Human (Biotinylated, HEK293, His-Avi) is the recombinant human-derived LAG-3 protein, expressed by HEK293 , with C-Avi, C-6*His labeled tag.

HY-P790057

	LAG-3 Protein, Canine (HEK293, Flag, His) Lymphocyte activating 3	Canine	HEK293
	LAG-3 (lymphocyte activation gene 3) protein is expressed on antigen-activated T cells and transmits inhibitory signals by binding to ligands such as FGL1. FGL1 is the main ligand responsible for the suppressive function of LAG3 T cells. LAG-3 Protein, Canine (HEK293, Flag, His) is the recombinant canine-derived LAG-3 protein, expressed by HEK293 , with C-His, C-Flag labeled tag.

HY-P78443

	FGL1 protein, Human (HEK293, 242a.a, His-Avi) FGL1; FGL-1; Hepassocin; HP-041; HFREP-1; LFIRE-1; HFREP1; LAG3 ligand	Human	HEK293
	FGL1 protein is the main ligand of LAG3 and can inhibit antigen-specific T cell activation, mediating the inhibitory function of LAG3 independently of MHC-II binding. FGL1 is secreted by liver cells and contributes to their growth.FGL1 protein, Human (HEK293, 242a.a, His-Avi) is the recombinant human-derived FGL1 protein, expressed by HEK293 , with N-His, N-Avi labeled tag.

HY-P701077

	FGL1 Protein, Human (Biotinylated, 242a.a, HEK293, hFc) FGL1; FGL-1; Hepassocin; HP-041; HFREP-1; LFIRE-1; HFREP1; LAG3 ligand	Human	HEK293
	FGL1 protein is the main ligand of LAG3 and can inhibit antigen-specific T cell activation, mediating the inhibitory function of LAG3 independently of MHC-II binding. FGL1 is secreted by liver cells and contributes to their growth. FGL1 Protein, Human (Biotinylated, 242a.a, HEK293, hFc) is the recombinant human-derived FGL1 protein, expressed by HEK293 , with N-hFc labeled tag.

HY-P78128

	FGL1 Protein, Human (Biotinylated, 242a.a, HEK293, His-Avi) FGL1; FGL-1; Hepassocin; HP-041; HFREP-1; LFIRE-1; HFREP1; LAG3 ligand	Human	HEK293
	FGL1 protein is the main ligand of LAG3 and can inhibit antigen-specific T cell activation, mediating the inhibitory function of LAG3 independently of MHC-II binding. FGL1 is secreted by liver cells and contributes to their growth. FGL1 Protein, Human (Biotinylated, 242a.a, HEK293, His-Avi) is the recombinant human-derived FGL1 protein, expressed by HEK293 , with N-Avi, N-His labeled tag.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Species
Source
Tag
Accession
Gene ID
Molecular Weight
Purity
Endotoxin Level
Biological Activity
Appearance
Formulation
Storage & Stability
Shipping
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Cat. No.	Compare	Product Name	Application	Reactivity

HY-P81716

	LAG3 Antibody (YA1461) LAG3; FDC; Lymphocyte activation gene 3 protein; LAG-3; Protein FDC; CD223	FC, ELISA	Human
	LAG3 Antibody (YA1461) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1461), targeting LAG3. LAG3 Antibody (YA1461) can be used for FC, ELISA experiment in human background.

HY-P84145

	CD223 Antibody (YA3842) LAG3	WB, FC, ELISA	Human

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Host
Reactivity
Application
Dilution Ratio
Molecular Weight
Conjugation
Clonality
Immunogen
Appearance
Isotype
Gene ID
SwissProt ID
Purity
Formulation
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Inquiry Online

Your information is safe with us. * Required Fields.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: